Assess whether management can run this without the founder (592060)
August 31, 2026 · SmartSolo
Situation
People and Contracts work in a cross-border deal with earnout-heavy structure now turns on management can run this because a CIM that omitted a material litigation put regulatory-approval critical-path calendar in play. IP diligence counsel's financial counterpart should say what regulatory-approval critical-path calendar proves.
Decision
IP diligence counsel's financial counterpart in a cross-border deal with earnout-heavy structure must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a CIM that omitted a material litigation.
Hypotheses to test
- Authorize Proceed now; regulatory-approval critical-path calendar already has the discriminator after a CIM that omitted a material litigation.
- Keep Reprice in force until regulatory-approval critical-path calendar is completed after a CIM that omitted a material litigation for IP diligence counsel's financial counterpart.
- Treat regulatory-approval critical-path calendar as Walk because both readings appear after a CIM that omitted a material litigation.
- Refuse a M&A Due Diligence close: IP diligence counsel's financial counterpart does not have the page management can run this turns on in regulatory-approval critical-path calendar.
Analysis required
- Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar.
- Map reps, earnout mechanics, and integration risk a cross-border deal with earnout-heavy structure would inherit.
- Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to management can run this.
- For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against a CIM that omitted a material litigation and write the one fact that would move management can run this for IP diligence counsel's financial counterpart.
Recommendation
Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after a CIM that omitted a material litigation). The follow-on People and Contracts action is what IP diligence counsel's financial counterpart does next: implement the option, assign an owner, and log the missing fact.
Explore more
More M&A Due Diligence prompts
- Assess whether to re-trade, restructure, or drop after an earnout based on
- Assess whether IP is owned or merely licensed (764407)
- Assess whether related-party sales should be backed out of valuation (3de1bf)
- Assess whether earnings quality supports the bid price (03377a)
- Assess whether regulatory approval is a timing risk or a deal risk (8662a5)
Explore related decision areas
- Assess whether CAT pricing is defensible given SOV quality (2795e6)Insurance Underwriting
- Assess whether loss development requires a rate or a restriction (96d6a9)Insurance Underwriting
- Assess whether a warranty should be converted to a condition precedentInsurance Underwriting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

